Correct regulation of DNA nucleotide biosynthesis is emerging as a key issue of importance for genome integrity. The fission yeast Spd1 protein can modulate the activity of ribonucleotide reductase (RNR) by at least three different mechanisms. Now a paper reports that Spd1 turnover is linked to ongoing DNA synthesis.
According to current thinking in the field [1] cancer development can be initiated by special 'oncogenic' S phases, where mutations in proto-oncogenes cause replication stress. This in turn may lead to replication fork collapse and the generation of DNA double strand breaks (DSBs). In order to prevent tumor progression, the organism relies on p53-mediated senescence or apopotosis in such precancerous cells. Cancer develops when this barrier breaks down by mutational inactivation of the DNA damage response pathway.
The exact mechanisms by which oncogene activation generates replication problems remain elusive, but an intriguing paper published last year implicated the availability of DNA building blocks in the process [2] . The authors induced oncogenic stress in primary cells by deregulating the Rb-E2F pathway, which normally activates S phase. As expected, this gave rise to severe S phase problems manifested as shorter inter-origin distances, slower fork progression and massive formation of DSBs. Interestingly, the authors found this oncogenic S phase was accompanied by a significant reduction in cellular deoxynucleotide (dNTP) pools, possibly due to the inability of the cells to up-regulate nucleotide biosynthesis to match the increased DNA replication activity. Furthermore, the S phase problems could largely be reversed by exogenous supply of nucleosides. Hence, this study suggests that the correct supply of DNA building blocks during S phase is important for genome stability and for the prevention of cancer.
Studies of the Spd1 protein in fission yeast point in the same direction. Spd1, a fascinating small, intrinsically disordered protein (IDP) that we are only beginning to understand the molecular function of [3] , was first identified in a screen for genes that inhibit S phase when over-expressed [4] . Subsequent studies showed that cells get rid of their Spd1 protein via ubiquitylation-mediated proteolysis whenever they need to synthesize DNA [5] . Spd1 degradation becomes activated when cells enter S phase by transcriptional induction of Cdt2, a substrate adaptor for the E3 ubiquitin ligase CRL4 [6] . CRL4-Cdt2 defective cells therefore undergo DNA replication in the presence of Spd1, and this process is very similar to the oncogenic S phase described above: replication proceeds slowly, with concomitant generation of DSBs and activation of the ATR/Rad3 checkpoint [5, 7, 8] . Interestingly, the activation of (and requirement for) a functional Rad3/ATR pathway in CRL4-Cdt2 defective cells is fully reversed by deletion of the spd1 gene, demonstrating that Spd1 is the major CRL4-Cdt2 substrate causing replication stress in fission yeast [5, 7] . Cdt2 can also be induced to down-regulate Spd1 during repair synthesis by a Rad3/ATR-dependent pathway [5, 9] . Since its accumulation in itself causes activation of the Rad3/ATR pathway, Spd1 can therefore trigger its own degradation.
But how does Spd1 inhibit S phase? A first clue to its molecular target came from the observation that the phenotype associated with Spd1 accumulation is very similar to that observed when treating cells with hydroxyurea [4] , a drug that causes reduced production of dNTPs via inhibition of the enzyme ribonucleotide reductase (RNR). The type 1a class of RNRs found in eukaryotes consists of a heterotetramer composed of two large catalytic R1 subunits, and two small R2 subunits which generate the tyrosyl free radical required for catalysis [10] . Hydroxyurea inhibits RNR function by acting as a scavenger of this radical. Consistent with a role for Spd1 in inhibiting RNR, CRL4-Cdt2 defective ddb1 cells have reduced dNTP pools, and this effect is reversed by spd1 loss [7] . Direct evidence linking Spd1 to RNR inhibition was provided when Antony Carr's lab reported that the S phase problems associated with Spd1 accumulation could be overcome by overexpressing the small R2 subunit (called Suc22 in fission yeast) [5] . Curiously, overexpression of the large subunit (Cdc22) did not have a similar effect [11] . Furthermore, it was reported that in the presence of Spd1 the R2 subunit of RNR was kept in the cell nucleus, away from the R1 subunit, which is mainly cytoplasmic, potentially providing a mechanism for RNR inhibition [5, 12] . However, subsequent in vitro studies reported that Spd1 could also inhibit RNR activity directly by binding to the large R1 subunit [13] .
Scanning mutagenesis of the spd1 gene demonstrated that these two RNR inhibitory effects could be genetically separated, and that R1 inhibition rather than nuclear import of R2 was causing Rad3/ATR activation in Spd1-accumulating cells [3] . The biological significance of R2 nuclear import is thus unclear, but recently it has been proposed that RNR in mammalian cells is activated directly at sites of damage [14] . Interestingly, in the distantly related budding yeast Saccharomyces cerevisiae, the two Spd1-related IPDs, Sml1 and Dif1, have similarly been reported to, respectively, inhibit R1 and sequester R2 to the nucleus. Synteny analysis suggests that these two genes arose by gene duplication of a common ancestor with both functions, similar to fission yeast Spd1 [15] . Hence, Spd1-mediated RNR repression is evolutionarily conserved, at least in fungi. Finally, Nestoras et al. [3] identified yet a third molecular function of Spd1: when the R1 and R2 subunits are tagged with different fluorescent proteins, a FRET (fluorescence resonance energy transfer) reaction is observed between them, but only in cells expressing Spd1. How the underlying conformational change in RNR architecture affects its activity is unknown.
A new paper from Stephen Kearsey's group, published in this issue of Current Biology, reports that Spd1 degradation is linked to active replication [16] . The paper presents evidence that Spd1, similar to other CRL4-Cdt2 substrates [17] , requires interaction with the polymerase processivity factor PCNA in order to become degraded. Inhibition of PCNA loading onto DNA (by inactivation of replication factor C), or prevention of CRL4-Cdt2 recruitment onto PCNA (by a point mutation in PCNA) both abolish damage-induced Spd1 turnover. The authors identify a somewhat degenerate PIP (PCNA Interaction Protein)-degron in Spd1, and provide genetic evidence that this region is important for Spd1 turnover. Finally, by means of bimolecular fluorescence complementation (BiFC) it is shown that Spd1 and PCNA can interact in vivo, in a PIP-sequence-dependent manner. Taken together, these observations demonstrate that Cdt2 induction is necessary but not sufficient for Spd1 proteolysis. In addition, interaction of Spd1 with PCNA is required to activate the CRL4-Cdt2 E3 ligase, and this is only possible when active replication causes loading of PCNA onto DNA.
What is the biological function of Spd1? We cannot exclude that the protein is merely ensuring repression of total dNTP production when DNA synthesis is not taking place, but perhaps Spd1 plays an important role in targeting dNTP production to replication and repair factories. In general, the phenotypes associated with excess Spd1 are much more severe than those caused by Spd1 loss. Elevated Spd1 levels (observed e.g. in cdt2-deleted cells) cause a strong checkpoint activation, presumably signalled by single-stranded DNA formation due to lowering of dNTP pools upon RNR inhibition (although it cannot be excluded that elevated Spd1 levels may also cause checkpoint activation by jamming other processes at PCNA). In view of the new findings of Salguero et al. [16] , it is tempting to speculate that an initial increase in Spd1 concentration caused by blocked replication, e.g. after damage, might contribute to checkpoint activation. The activated checkpoint then would cause Cdt2 induction [6] and repair synthesis, which depends on PCNA loading. The combination of the two would drive Spd1 degradation to provide dNTPs for repair synthesis [9, 16] . It is intriguing that S phase in the presence of Spd1 in fission yeast resembles replication stress imposed by certain oncogenes in mammalian cells, and it will be interesting to learn if metazoan cells also modulate their RNR activity by small IDPs. Yet, the limited sequence conservation of this interesting protein family has thus far prevented their identification. Insects, with their remarkable learning capacities and relatively simple and accessible nervous systems, provide powerful models for studying associative learning and memory [1] [2] [3] [4] . The combination of procedures for classical conditioning with the disruptive methods of genetics has made it possible to identify cellular and molecular substrates of memory in some species, such as the honey bee Apis mellifera and the fruit fly Drosophila melanogaster. These studies established the mushroom bodies, paired central structures in the insect brain, as a key site for the formation of long-term memories. A recent study [5] of fruit fly learning has attributed this role to two neurons external to mushroom bodies and
